199 related articles for article (PubMed ID: 21964595)
41. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
[TBL] [Abstract][Full Text] [Related]
42. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
Craig JM; Turner TH; Harrell JC; Clevenger CV
Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
[TBL] [Abstract][Full Text] [Related]
43. Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy.
Qin JJ; Wang W; Sarkar S; Voruganti S; Agarwal R; Zhang R
Oncotarget; 2016 May; 7(22):32566-78. PubMed ID: 27105525
[TBL] [Abstract][Full Text] [Related]
44. NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the alpha-helical region of the STAT5 transactivation domain.
Litterst CM; Kliem S; Marilley D; Pfitzner E
J Biol Chem; 2003 Nov; 278(46):45340-51. PubMed ID: 12954634
[TBL] [Abstract][Full Text] [Related]
45. Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.
Yang N; Liu C; Peck AR; Girondo MA; Yanac AF; Tran TH; Utama FE; Tanaka T; Freydin B; Chervoneva I; Hyslop T; Kovatich AJ; Hooke JA; Shriver CD; Rui H
Breast Cancer Res; 2013; 15(5):R73. PubMed ID: 24004716
[TBL] [Abstract][Full Text] [Related]
46. FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.
Oskay Halacli S
Cell Biol Int; 2017 Jan; 41(1):102-110. PubMed ID: 27859969
[TBL] [Abstract][Full Text] [Related]
47. Conversion of threonine 757 to valine enhances Stat5a transactivation potential.
Gowri PM; Ganguly TC; Cao J; Devalaraja MN; Groner B; Vore M
J Biol Chem; 2001 Mar; 276(13):10485-91. PubMed ID: 11133982
[TBL] [Abstract][Full Text] [Related]
48. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway.
Granja AG; Nogal ML; Hurtado C; Vila V; Carrascosa AL; Salas ML; Fresno M; Revilla Y
J Biol Chem; 2004 Dec; 279(51):53736-46. PubMed ID: 15471864
[TBL] [Abstract][Full Text] [Related]
49. Reciprocal effects of STAT5 and STAT3 in breast cancer.
Walker SR; Nelson EA; Zou L; Chaudhury M; Signoretti S; Richardson A; Frank DA
Mol Cancer Res; 2009 Jun; 7(6):966-76. PubMed ID: 19491198
[TBL] [Abstract][Full Text] [Related]
50. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1.
Terui Y; Saad N; Jia S; McKeon F; Yuan J
J Biol Chem; 2004 Jul; 279(27):28257-65. PubMed ID: 15117942
[TBL] [Abstract][Full Text] [Related]
51. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
Wu AM; Dalvi P; Lu X; Yang M; Riddick DS; Matthews J; Clevenger CV; Ross DD; Harper PA; Ito S
Mol Pharmacol; 2013 Feb; 83(2):377-88. PubMed ID: 23150485
[TBL] [Abstract][Full Text] [Related]
52. Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.
Rädler PD; Wehde BL; Wagner KU
Mol Cell Endocrinol; 2017 Aug; 451():31-39. PubMed ID: 28495456
[TBL] [Abstract][Full Text] [Related]
53. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
54. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
[TBL] [Abstract][Full Text] [Related]
55. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes.
Luo C; Burgeon E; Carew JA; McCaffrey PG; Badalian TM; Lane WS; Hogan PG; Rao A
Mol Cell Biol; 1996 Jul; 16(7):3955-66. PubMed ID: 8668213
[TBL] [Abstract][Full Text] [Related]
56. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer.
Chen ZL; Zhao SH; Wang Z; Qiu B; Li BZ; Zhou F; Tan XG; He J
Chin J Cancer; 2011 Jan; 30(1):62-8. PubMed ID: 21192845
[TBL] [Abstract][Full Text] [Related]
57. Delivery of the VIVIT Peptide to Human Glioma Cells to Interfere with Calcineurin-NFAT Signaling.
Ellert-Miklaszewska A; Szymczyk A; Poleszak K; Kaminska B
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443374
[TBL] [Abstract][Full Text] [Related]
58. Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells.
Robledo T; Arriaga-Pizano L; Lopez-Pérez M; Salazar EP
Matrix Biol; 2005 Oct; 24(7):469-77. PubMed ID: 16139998
[TBL] [Abstract][Full Text] [Related]
59. Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.
Qian L; Lopez V; Seo YA; Kelleher SL
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C369-77. PubMed ID: 19494234
[TBL] [Abstract][Full Text] [Related]
60. Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter.
Fang F; Antico G; Zheng J; Clevenger CV
BMC Biotechnol; 2008 Feb; 8():11. PubMed ID: 18254957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
